326 related articles for article (PubMed ID: 16369769)
1. Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.
Osadchii OE; Woodiwiss AJ; Norton GR
Pflugers Arch; 2006 May; 452(2):155-63. PubMed ID: 16369769
[TBL] [Abstract][Full Text] [Related]
2. Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats.
Osadchii OE; Woodiwiss AJ; Deftereos D; Norton GR
Pflugers Arch; 2007 Nov; 455(2):251-60. PubMed ID: 17558518
[TBL] [Abstract][Full Text] [Related]
3. Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats.
Osadchii O; Norton G; Woodiwiss A
Eur J Pharmacol; 2005 May; 514(2-3):201-8. PubMed ID: 15910807
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic inotropic downregulation.
Osadchii O; Woodiwiss A; Alves N; Norton G
Life Sci; 2005 Dec; 78(4):366-75. PubMed ID: 16137710
[TBL] [Abstract][Full Text] [Related]
5. Impact of chronic beta-adrenoceptor activation on neurotensin-induced myocardial effects in rats.
Osadchii O; Norton G; Deftereos D; Muller D; Woodiwiss A
Eur J Pharmacol; 2006 Dec; 553(1-3):246-53. PubMed ID: 17056037
[TBL] [Abstract][Full Text] [Related]
6. Rat strain-related differences in myocardial adrenergic tone and the impact on cardiac fibrosis, adrenergic responsiveness and myocardial structure and function.
Osadchii O; Norton G; Deftereos D; Woodiwiss A
Pharmacol Res; 2007 Apr; 55(4):287-94. PubMed ID: 17257851
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
Belhassen L; Kelly RA; Smith TW; Balligand JL
J Clin Invest; 1996 Apr; 97(8):1908-15. PubMed ID: 8621775
[TBL] [Abstract][Full Text] [Related]
8. Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.
Osadchii OE; Norton GR; McKechnie R; Deftereos D; Woodiwiss AJ
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1898-905. PubMed ID: 17158652
[TBL] [Abstract][Full Text] [Related]
9. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
10. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3',5'-adenosine monophosphate.
Ririe DG; Butterworth JF; Royster RL; MacGregor DA; Zaloga GP
Anesthesiology; 1995 Apr; 82(4):1004-12. PubMed ID: 7717535
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation.
Veliotes DG; Woodiwiss AJ; Deftereos DA; Gray D; Osadchii O; Norton GR
Hypertension; 2005 May; 45(5):914-20. PubMed ID: 15837836
[TBL] [Abstract][Full Text] [Related]
12. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
[TBL] [Abstract][Full Text] [Related]
13. Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease.
Osadchii OE
Cardiovasc Drugs Ther; 2007 Jun; 21(3):171-94. PubMed ID: 17373584
[TBL] [Abstract][Full Text] [Related]
14. Attenuated beta-adrenoceptor-mediated cardiac contractile responses following androgenic steroid administration to sedentary rats.
Norton GR; Trifunovic B; Woodiwiss AJ
Eur J Appl Physiol; 2000 Mar; 81(4):310-6. PubMed ID: 10664090
[TBL] [Abstract][Full Text] [Related]
15. Sex differences and the effects of ovariectomy on the β-adrenergic contractile response.
McIntosh VJ; Chandrasekera PC; Lasley RD
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1127-34. PubMed ID: 21685268
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
[TBL] [Abstract][Full Text] [Related]
17. Myocardial structural, contractile and electrophysiological changes in the guinea-pig heart failure model induced by chronic sympathetic activation.
Soltysinska E; Olesen SP; Osadchii OE
Exp Physiol; 2011 Jul; 96(7):647-63. PubMed ID: 21571815
[TBL] [Abstract][Full Text] [Related]
18. Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction.
Soltysinska E; Thiele S; Olesen SP; Osadchii OE
Pflugers Arch; 2011 Oct; 462(4):529-43. PubMed ID: 21811789
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
[TBL] [Abstract][Full Text] [Related]
20. Propofol attenuates beta-adrenoreceptor-mediated signal transduction via a protein kinase C-dependent pathway in cardiomyocytes.
Kurokawa H; Murray PA; Damron DS
Anesthesiology; 2002 Mar; 96(3):688-98. PubMed ID: 11873046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
